Genprex, Inc. (GNPX) vs NEXGEL, Inc. (NXGL)

A side-by-side comparison of Genprex, Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GNPX

Genprex, Inc.

$1M

$2.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NXGL

NEXGEL, Inc.

$1M

$0.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GNPX vs NXGL

growth of $100 · dividends reinvested · last 5y

GNPX -100.0% (-86.5%/yr)NXGL -95.2% (-45.5%/yr)NXGL compounded faster over this window

Log scale — wide-divergence pair

GNPX NXGL

GNPX vs NXGL: by the numbers

•NXGL is the larger company ($1M vs $1M market cap).
•Both run net losses; GNPX's is the smaller (0.00% vs -51.26% net margin).

Metrics side by side

Valuation

Metric	GNPX	NXGL
P/S ratio	N/A	0.12
P/B ratio	0.09	0.30

Profitability

Metric	GNPX	NXGL
Gross margin	0.00%	35.07%
Operating margin	0.00%	-29.35%
Net margin	0.00%	-51.26%
ROE	-111.51%	-124.97%
ROIC	-107.08%	-41.80%

Growth (annualized)

Metric	GNPX	NXGL
Revenue CAGR (5Y)	N/A	63.69%
Total return CAGR (5Y)	-88.16%	N/A

Go deeper

Full GNPX analysis Full NXGL analysis Interactive comparison tool

Dig into the metrics

Genprex ROE NEXGEL ROE Genprex operating margin NEXGEL operating margin Genprex revenue growth NEXGEL revenue growth Genprex free cash flow NEXGEL free cash flow

Genprex & NEXGEL appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.